Market Cap | ₹13Cr |
ROE | 0.36% |
P/E Ratio(TTM) | 836.00 |
EPS(TTM) | 0.03 |
P/B Ratio | 2.99 |
Dividend Yield | 0.00% |
Industry P/E | 40.04 |
Book Value | 8.38 |
Debt to Equity | 0.01 |
Face Value | 10 |
Parent Organisation | Venmax Drugs & Pharmaceuticals Limited |
BSE Symbol | 531015 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 69.18 | ||
Neuland Laboratories | NA (0.00%) | 105.31 | ||
Jubilant Pharmova | NA (0.00%) | 37.03 | ||
Acutaas Chemicals | NA (0.00%) | 63.39 |